A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal

American Journal on Addictions

Volumn 7, Issue 3, 1998, Pages 189-197

  Rosenthal, Richard N ^a   Ferkel, Charles ^a   Singh, Prameet ^a   Anand, Om ^a   Miner, Christian R ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL; VALPROIC ACID;

ADULT; ALCOHOL WITHDRAWAL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HOSTILITY; HUMAN; MOOD; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL SYNDROME;

EID: 0031815191     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1521-0391.1998.tb00336.x     Document Type: Article

References (42)

1. Brownell KD, Marlatt GA, Lichtenstein E, et al: Understanding and preventing relapse. Am Psychol 1986; 41:765-782
2. McMahon RC, Davidson RS: Patterns of stability and change in mood states of alcoholics in inpatient treatment. International Journal of Addictions 1986; 21:923-927
3. Marlatt GA, Gordon JR: Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York, Guilford, 1985
4. Schuckit MA, Hesselbrock VM: Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 1994; 151:1723-1734
5. Weiss KJ, Rosenberg DJ: Prevalance of anxiety disorder among alcoholics. J Clin Psychiatry 1985; 46:3-5
6. Schuckit MA: Anxiety disorders and substance abuse, in American Psychiatric Press Review of Psychiatry, edited by Tasman A, Riba M. Washington, DC, American Psychiatric Press, 1992, vol 11, chapter 20, pp 402-407
7. Nutt D, Adinoff B, Linnoila M: Benzodiazepines in the treatment of alcoholism. Recent Dev Alcohol 1989; 7:283-313
8. Keck PE, McElroy SL, Friedman LM: Valproate and carbamazepine in the treatment of panic and post-traumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 1992; 12:36S-41S
9. Roy-Byrne PP, Ward NG, Donnelly PJ: Valproate in anxiety and withdrawal syndromes. J Clin Psychiatry 1989; 50(suppl):44-48
10. Flygenring J, Hansen J, Holst B, et al: Treatment of alcohol withdrawal symptoms in hospitalized patients: a randomized, double-blind comparison of carbamazepine (Tegretol) and barbital (Diemal). Acta Psychiatr Scand 1984; 69:398-408
11. Agricola R, Mazzarino M, Urani R: Treatment of acute alcohol withdrawal syndrome with carbamazepine: a double-blind comparison with with tiapride. J Int Med Res 1982; 10:160-165
12. Ritola E, Malinen L: A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 1981; 64:254-259
13. Malcolm R, Ballenger JC, Sturgis ET, et al: Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrwawal. AmJ Psychiatry 1989; 146:617-621
14. Hillbom M, Tokola R, Kuusela V, et al: Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol (Eng) 1989; 6:223-226
15. Anton RF, Kranzler HR, McEvoy JP, et al: A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal. Psychopharmacology (Berl) 1997; 131:123-129
16. Loscher W, Honack D: Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil. Naunyn Schmiedebergs Arch Pharmacol 1992; 345:452-460
17. Hillbom ME: The prevention of ethanol withdrawal seizures in rats by dipropylacetate. Neuropharmacology 1975; 14:755-761
18. Noble EP, Gillies R, Vigran R, et al: The modification of the ethanol wihdrawal syndrome in rats by di-n-propyl acetate. Psychopharmacologia 1976; 46:127-131
19. Lambie DG, Johnson RH, Vijayasenan ME, et al: Sodium valproate in the treatment of the alcohol withdrawal syndrome. Aust N Z J Psychiatry 1980; 14:213-215
20. Penry JK: Monotherapy of primary generalized seizures, in Diagnosis and Management of Epilepsy. New York, Biomedical Information Corporation, 1986, pp 9-15
21. Hammer BA, Brady KT: Valproate treatment of alcohol withdrawal and mania. Am J Psychiatry 1996; 9:1232
22. Allen AM, Harris RA: Involvement of neuronal chloride channels in ethanol intoxication, tolerance and dependence, in Recent Developments in Alcoholism, edited by Galanter M. New York, Plenum, 1986, pp 313-325
23. Areceptor. Alcohol Health & Research World 1997; 21:127-131
24. Tran VT, Snyder SH, Major LF, et al: GABA receptors are increased in brains of alcoholics. Ann Neurol 1981; 9:189-192
25. Petty F, Sherman AD: Plasma GABA levels in psychiatric illness. J Affect Dis 1984; 6:131-138
26. Finn DA, Crabbe JC: Exploring alcohol withdrawal syndrome. Alcohol Health & Research World 1997; 21:149-156
27. Wilbur R, Kulik FA: Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants. American Journal of Hospital Pharmacy 1981; 38:1138-1143
28. Klotz U, Rapp T, Müller WA: Disposition of valproic acid in patients with liver disease. European Journal of Clinical Pharmacology 1978; 13:55-60
29. Hillbom ME, Hjelm-Jager M: Should alcohol withdrawal seizures be treated with anti-epileptic drugs? Acta Neurol Scand 1984; 69:39-42
30. Rosenfeld WE, Leppik IE, Gates JR, et al: Valproic acid loading during intensive monitoring. Arch Neurol 1987; 44:709-710
31. Becker HC, Hale RL: Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal kindling. Alcoholism Clin Exp Res 1993; 17:94-98
32. Brown ME, Anton RF, Malcolm R, et al: Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry 1988; 23:507-514
33. Gross MM, Lewis E, Nagarajan M: An improved quantitative system for assessing the acute alcohol psychoses and related states (TSA and SSA), in Alcohol Intoxication and Withdrawal: Experimental Studies, Advances in Experimental Medicine and Biology, edited by Gross MM. New York, Plenum, 1973, vol. 35, pp 365-376
34. Benzer DG: Quantification of the alcohol withdrawal syndrome in 487 alcoholic patients. Journal of Substance Abuse Treatment 1990; 7:117-123
35. Schmauss C, Apelt S, Emrich HM: Characterization of benzodiazepine withdrawal in high-and low-dose dependent psychiatric inpatients. Brain Res Bull 1987; 19:393-400
36. McNair PM, Lorr M, Droppleman LF: POMS Manual, 2nd Edition. San Diego, CA, Education and Industrial Testing Service, 1981
37. Shacham S: A shortened version of the Profile of Mood States. J Pers Assess 1983; 47:305-306
38. Buss AH, Durkee A: An inventory for assessing different kinds of hostility. J Consult Clin Psychol 1957; 4:343-349
39. Schill T, Ramanaiah N, Conn SR: Development of covert and overt hostility scales from the Buss-Durkee Inventory. Psychol Rep 1990; 67:671-674
40. SYSTAT: Statistics, Version 5.2.1 Edition. Evanston, IL, SYSTAT Inc., 1992
41. Brady KT, Sonne SC, Anton R, et al: Valproate in the treatment of acute bipolar affective disorders complicated by substance abuse: a pilot study. J Clin Psychiatry 1995; 56:118-121
42. Minuk GY, Rockman GE, German GB, et al: The use of sodium valproate in the treatment of alcoholism. J Addict Dis 1995; 14:67-74